ADNYX | PMAQX | ADNYX / PMAQX | |
Total Expense Ratio | 1.09 | 0.60 | 182% |
Annual Report Gross Expense Ratio | 1.17 | 0.60 | 195% |
Fund Existence | 8 years | 8 years | - |
Gain YTD | -18.452 | -2.980 | 619% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 150M | 28.9B | 1% |
Annual Yield % from dividends | 0.00 | 0.20 | - |
Returns for 1 year | 5.77 | 7.10 | 81% |
Returns for 3 years | -17.98 | 22.87 | -79% |
Returns for 5 years | -37.45 | 70.74 | -53% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MTUM | 204.82 | 4.49 | +2.24% |
iShares MSCI USA Momentum Factor ETF | |||
HQH | 16.13 | 0.35 | +2.22% |
abrdn Healthcare Investors | |||
EDOG | 21.32 | 0.28 | +1.32% |
ALPS Emerging Sector Dividend Dogs ETF | |||
NUEM | 29.10 | 0.03 | +0.10% |
Nuveen ESG Emerging Markets Equity ETF | |||
PHDG | 33.81 | -0.21 | -0.61% |
Invesco S&P 500® Downside Hedged ETF |